Study of a new drug with amiodarone and febuxostat in healthy adults
Treatments studied
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks how a new drug interacts with two other medicines (amiodarone and febuxostat) in healthy volunteers. It helps doctors understand safe dosing before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old
- You must be in good health with no major medical conditions
- Your body mass index (BMI) must be between 18 and 32
- You must be willing to use highly effective birth control (if applicable) and not donate sperm or eggs during the study
- You must not have allergies to the study drugs, foods, or other substances
- You must not have conditions that affect drug absorption, such as certain stomach or intestinal problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new investigational medicine called PYC-003 for people with autosomal dominant polycystic kidney disease (ADPKD). It is one of the first studies in humans, so the main goal is to see if the medicine is safe and tolerable. The study is for people with a specific genetic cause (PKD1 mutation) and with certain kidney imaging types.
This study tests how a new drug, VX-407, affects the levels of a combined oral contraceptive in your body. Participants must be healthy adults aged 18 to 65 with a certain body weight and BMI.
This study gives a single dose of the study drug VX-407 to see how it is absorbed, broken down, and removed from the body. It helps researchers understand how the drug works in people.
This study is for healthy volunteers to see how a new experimental drug (JMKX003142) interacts with other drugs in the body. It helps find the right dose for future patients.
This study tests a new medicine (JMKX003142) in healthy adults to see if it affects the heart's rhythm. If you qualify, you may help determine whether the drug is safe to use in future patients.
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
Hear when a new Autosomal Dominant Polycystic Kidney Disease (ADPKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.